Data Analytics
Organize the Korean life science startup and global stakeholder landscape as actionable data.
With digital transformation and AI, we connect innovators with the right investors and partners to maximize the chance that early-stage healthcare innovation becomes a successful business.
320+
Investors
$ 2,931K+
Deal size
45+
Countries reached
2020.12
Founded
2021.08
Certified venture company
2021.12
Seed investment
2022.05
Pre-Series A investment
2022.08
Scoring service patent filed
2023.06
IR book business launched
2023.07
Selected for startup support
2024.03
Biobook MVP launched
2025.08
Accelerator license acquired
Organize the Korean life science startup and global stakeholder landscape as actionable data.
Structure early-company growth potential by looking at technology, stage, and marketability together.
Explore the life science ecosystem quickly and find relevant targets through intelligent search.
Create connection points where innovators, investors, and pharma communities can collaborate.
Clarify the company and technology story through tailored IR books and company materials.
Use a broad network to identify ideal business partner candidates.
Support cross-border transactions and partnering discussions with an experienced advisory team.
Provide expert insight and materials for validating life science technology investments.